Advantages of CPAPn therapy in OSAS patients with cardiac rhythm complications

G. Massari, R. Malorgio, G. Manca, E. Scoditti, E. Sabato, S. Scoditti (Lecce, Brindisi, San Cesario di Lecce, Zingonia, Italy)

Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Massari, R. Malorgio, G. Manca, E. Scoditti, E. Sabato, S. Scoditti (Lecce, Brindisi, San Cesario di Lecce, Zingonia, Italy). Advantages of CPAPn therapy in OSAS patients with cardiac rhythm complications. Eur Respir J 2010; 36: Suppl. 54, 938

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of delirium after cardiac surgery in patients with sleep disordered breathing
Source: Eur Respir J, 54 (2) 1900354; 10.1183/13993003.00354-2019
Year: 2019



Severe bradyarrhythmias in pts with sleep apnea hypopnea syndrome (OSAHS) and the effect of CPAP treatment. A long-term study with the use of implantable loop recorders
Source: Eur Respir J 2003; 22: Suppl. 45, 23s
Year: 2003

Sleep-related breathing disorders in patients under cardiac resynchronization therapy with ventricular pacing
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

28-day post-operative complications in elective bariatric patients with obstructive sleep apnoea
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018

Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Role of aerosolized therapy in the incidence of cardiac rythm disturbances in patients hospitalized with a COPD exacerbation
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


CPAP and measures of cardiovascular risks in patients with OSAS
Source: Eur Respir J 2009; 33: 1520
Year: 2009


Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015

Effects of CPAP and mandibular advancement devices on cardiac biomarkers in patients with obstructive sleep apnea
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Study of autonomic dysfunction in patients with nocturnal hypoventilation treated with noninvasive ventilation
Source: Eur Respir J 2001; 18: Suppl. 33, 504s
Year: 2001

Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 564s
Year: 2004

Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012


OSAS in the perioperative period
Source: International Congress 2015 – Sleep-disordered breathing
Year: 2015



Evaluation of polysomnographic data in OSAS patients with cardiac diseases
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009

Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up
Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters?
Year: 2015